Allergic diseases include allergic rhinitis (hay fever), food allergies, forms of asthma, conjunctivitis, eczema, eosinophilic disorders, drug and insect allergies.
Diagnostic allergy testing in such scenarios is as an essential tool for evaluation of the patient.
Global Allergy Diagnostics market is anticipated to reach USD 4 billion by 2025.
Primary market drivers include rising allergic diseases with severe environmental pollution.
On the other hand, the growth of this market is hindered due to limited awareness about allergy diagnosis, food allergy, food intolerance and low affordability in developing countries.
Hence, allergic diseases like a food allergy and food intolerance are underestimated and underdiagnosed, particularly in low and middle-income countries.
Asia-Pacific is expected to show fast growth over the forecast period owing to an increase in pollution in developing countries like India and China.
Global Allergy Diagnostics market report segments the market by products, allergen type, test type, end-user and by region.
Based on product type, the market is classified into assay kits and consumables.
Based on the type of allergen responsible for causing allergy, the market is segmented into a drug, food, and inhaled allergens.
Inhaled allergens segment accounts for the largest share of Allergy Diagnostics market. Increasing environmental pollution is one of the major factors driving the growth of this segment.
Based on end-user, the market is segmented into diagnostic laboratories, hospital-based laboratories, academic & research institutes, diagnostics kits, and other end users.
In 2017, diagnostic laboratories segment accounted for the largest share.
Based on the type of test used for allergy testing, the market is segmented into two categories, namely In vivo test and In-vitro test.
In vivo test includes skin testing while in vitro test comprises serological tests.
The market is segmented into five major regions: North America, South America, Europe, Asia Pacific, and RoW.
North America holds the highest market share of around 40%.
This is fueled by the high incidence of allergies, the presence of advanced allergy diagnostic technologies, as well as the strong presence of players in the region.
By Product Type
By Allergen Type
Academic Research Laboratories
Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific)
Europe (Germany, France, The UK, Italy, Spain, Rest of Europe)
North America (The USA, Canada, Mexico)
South America (Brazil, Argentina, Rest of South America)
Rest of the World
Allergy Diagnostics Industry Competition Size
The report also profiles the following companies in Allergy Diagnostics Treatment market – BioMérieux, Danaher Corporation, GlaxoSmithKline plc, Hitachi Chemical Diagnostics, Inc., Merck & Co, Inc, Omega Diagnostics Group PLC, Siemens Healthcare, and Thermo Fisher Scientific, Inc
Reasons for purchasing this report
Visualize the composition of Allergy Diagnostics market across each indication, regarding type and treatment options, highlighting the critical commercial assets and players.
Identify commercial opportunities by analyzing trends.
Excel data sheet with thousands of data points of the market – level 4/5 segmentation.
PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
Product mapping in excel for crucial Allergy Diagnostics products of all major market players
Who are the key vendors in the allergy diagnostics market space?
Equipment Suppliers/ Buyers
Service Providers/ Buyers
Industry Investors/Investment Bankers
Education & Research Institutes
1.1 Research Methodology
1.2 Scope of the Report
2.1 Key Trends & Developments
3.1 Market Drivers
Environmental pollution contributing to the increasing incidence of allergic conditions
3.2 Market Restraints
Lack of awareness about allergic diseases
Low affordability of allergy diagnostics
3.3 Threats and Opportunities
3.4 Porter’s 5 Forces
4. Product-based Analysis
4.1 By Product Type
4.2 By Allergen Type
4.3 By End-User
Academic Research Laboratories
4.4 By Test Type
In vivo test
5. Regional, Country-level Analysis
5.1. North America
5.1.1. The USA
5.2.3. The UK
5.2.6. Rest of Europe
5.3. Asia Pacific
5.3.5. Rest of Asia Pacific
5.4. South America
5.4.3. Rest of South America
5.5 Rest of the World
6. Industry Competitiveness
6.1. Market Share Analysis
6.2. Mergers and Acquisitions Analysis
6.3. New Product Launches
7. Company Profiles
7.2 Danaher Corporation
7.3 GlaxoSmithKline Plc
7.4 Hitachi Chemical Diagnostics, Inc.
7.5 Merck & Co., Inc.
7.6 Omega Diagnostics Group PLC
7.7 Siemens Healthcare
7.8 Thermo Fisher Scientific, Inc.
8.2 List of Tables
8.3 Expert Panel Validation
8.5 Contact Us
Get your FREE SAMPLE PROPOSAL with a single click!